Literature DB >> 16369044

Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka.

Thilan Wickramarachchi1, Prasad H Premaratne, K L R Lakshman Perera, Sumith Bandara, Clemens H M Kocken, Alan W Thomas, Shiroma M Handunnetti, Preethi V Udagama-Randeniya.   

Abstract

Plasmodium vivax apical membrane antigen 1, an important malaria vaccine candidate, was immunogenic during natural malaria infections in Sri Lanka, where low transmission and unstable malaria conditions prevail. Antibody prevalence increased with exposure in areas where malaria was or was not endemic. A marked isotype switch to cytophilic (immunoglobulin G1 [IgG1]/IgG3) antibodies was evident with increasing exposure exclusively in residents from areas of endemicity.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16369044      PMCID： PMC1346644          DOI： 10.1128/IAI.74.1.798-801.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII.

Authors:  V Udhayakumar; S Kariuki; M Kolczack; M Girma; J M Roberts; A J Oloo; B L Nahlen; A A Lal
Journal:  Am J Trop Med Hyg       Date:  2001-08       Impact factor: 2.345

2.  Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.

Authors:  Maria Helena C Rodrigues; Karina M Rodrigues; Tatiane R Oliveira; Andréia N Cômodo; Mauricio M Rodrigues; Clemens H M Kocken; Alan W Thomas; Irene S Soares
Journal:  Int J Parasitol       Date:  2004-12-19       Impact factor: 3.981

3.  An enzyme-linked immunosorbent assay for the quantitation of human IgG subclasses using monoclonal antibodies.

Authors:  A Ferrante; B Rowan-Kelly; L J Beard; G M Maxwell
Journal:  J Immunol Methods       Date:  1986-11-06       Impact factor: 2.303

4.  Specificity of the protective antibody response to apical membrane antigen 1.

Authors:  A N Hodder; P E Crewther; R F Anders
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka.

Authors:  J Fonseka; K N Mendis
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

6.  Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies.

Authors:  C Mendis; A C Gamage-Mendis; A P De Zoysa; T A Abhayawardena; R Carter; P R Herath; K N Mendis
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

7.  Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes.

Authors:  Joanne L Casey; Andrew M Coley; Robin F Anders; Vince J Murphy; Karen S Humberstone; Alan W Thomas; Michael Foley
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

8.  Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.

Authors:  Sheetij Dutta; J David Haynes; J Kathleen Moch; Arnoldo Barbosa; David E Lanar
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-02       Impact factor: 11.205

9.  Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

Authors:  R A O'Donnell; T F de Koning-Ward; R A Burt; M Bockarie; J C Reeder; A F Cowman; B S Crabb
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

10.  Sri Lanka malaria maps.

Authors:  Olivier J T Briët; Dissanayake M Gunawardena; Wim van der Hoek; Felix P Amerasinghe
Journal:  Malar J       Date:  2003-07-22       Impact factor: 2.979
View more
  12 in total

1.  Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.

Authors:  Luciane M Storti-Melo; Wanessa C Souza-Neiras; Gustavo C Cassiano; Leonardo C Taveira; Antônio J Cordeiro; Vanja S C A Couto; Marinete M Póvoa; Maristela G Cunha; Diana M Echeverry; Andréa R B Rossit; Myriam Arévalo-Herrera; Sócrates Herrera; Ricardo L D Machado
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 2.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

3.  A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran.

Authors:  Afsaneh Motevalli Haghi; Mohammad Reza Khoramizade; Mehdi Nateghpour; Mehdi Mohebali; Gholam Hossein Edrissian; Mohammad Reza Eshraghian; Zargham Sepehrizadeh
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

4.  Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.

Authors:  Stella M Chenet; Lorena L Tapia; Ananias A Escalante; Salomon Durand; Carmen Lucas; David J Bacon
Journal:  Malar J       Date:  2012-03-14       Impact factor: 2.979

5.  High-Level Expression, Purification and Characterization of A Recombinant Plasmodium vivax Apical Membrane Antigen 1: Implication for vivax Malaria Vaccine Development.

Authors:  Maryam Salavatifar; Sedigheh Zakeri; Nasim Hayati Roodbari; Navid Dinparast Djadid
Journal:  Cell J       Date:  2015-10-07       Impact factor: 2.479

6.  Serologically defined variations in malaria endemicity in Pará state, Brazil.

Authors:  Maristela G Cunha; Eliane S Silva; Nuno Sepúlveda; Sheyla P T Costa; Tiago C Saboia; João F Guerreiro; Marinete M Póvoa; Patrick H Corran; Eleanor Riley; Chris J Drakeley
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

7.  Temporal genetic changes in Plasmodium vivax apical membrane antigen 1 over 19 years of transmission in southern Mexico.

Authors:  Alejandro Flores-Alanis; Lilia González-Cerón; Frida Santillán; Cecilia Ximenez; Marco A Sandoval; René Cerritos
Journal:  Parasit Vectors       Date:  2017-05-02       Impact factor: 3.876

8.  Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion.

Authors:  Thilan Wickramarachchi; Yengkhom S Devi; Asif Mohmmed; Virander S Chauhan
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

9.  A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.

Authors:  Jessica B Hostetler; Sumana Sharma; S Josefin Bartholdson; Gavin J Wright; Rick M Fairhurst; Julian C Rayner
Journal:  PLoS Negl Trop Dis       Date:  2015-12-23

10.  Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes.

Authors:  Gabriela Arévalo-Pinzón; Maritza Bermúdez; Diana Hernández; Hernando Curtidor; Manuel Alfonso Patarroyo
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.